Ledger.Open graph →
SEC Form D · filed January 11, 2021

ENB Therapeutics, Inc

Offering
$2.6M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Barbara Schilberg · New York, NYDirectorSumayah Jamal · New York, NYExec · DirectorFumitaka Mori · NEW YORK, NYDirectorAlbert Sokol · New York, NYExecStephen Buchanan · Charlotte, NCExecJoseph Strycharz · Charlotte, NCExec · DirectorBridget M. Cole · WALTHAM, MADirectorWilliam Hayes · Charlotte, NCDirectorJames Howes · Sydney NSW, Channel IslandsDirectorAndrew White · SANTA FE SPRINGS, CADirectorTejroop S. Sehmi · SANTA FE SPRINGS, CAExec · DirectorNavjot S. Sehmi · SANTA FE SPRINGS, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗